Corpus ID: 2794038

Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.

@article{Christensen2016GlucosedependentIP,
  title={Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.},
  author={M. Christensen},
  journal={Danish medical journal},
  year={2016},
  volume={63 4}
}
The hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are secreted by enteroendocrine cells in the intestinal mucosa in response to nutrient ingestion. They are called incretin hormones because of their ability to enhance insulin secretion. However, in recent years it has become clear that the incretin hormones also affect glucagon secretion. While GLP-1 decreases glucagon levels, the effect of GIP on glucagon levels has been unclear. The regulation… Expand
14 Citations
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
  • 14
Characterisation and antidiabetic utility of a novel hybrid peptide, exendin‐4/gastrin/xenin‐8‐Gln
  • 10
...
1
2
...

References

SHOWING 1-10 OF 67 REFERENCES
Effect of GIP and GLP-1 antagonists on insulin release in the rat.
  • 90
  • PDF
Insulin secretion in diabetes mellitus.
  • 375
  • PDF
...
1
2
3
4
5
...